Neumora Therapeutics, Inc. (NMRA)
0.5253
+0.03
(+5.08%)
USD |
NASDAQ |
Oct 05, 16:00
0.525
0.00 (0.00%)
Pre-Market: 08:07
Neumora Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| BioAge Labs, Inc. | 97.14% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -199.2% |
| Return on Assets | -122.0% |
| Return on Invested Capital | -144.6% |
| Return on Net Operating Assets | -45.44K% |